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Lowering private investor risk to build a 
healthier country
A slew of highly inno vative, 
private local and interna-
tional, socially conscious 
companies are starting to 
improve health care out-
comes in southern Africa – with some 
garnering investor returns of between 8% 
and 10% on debt funds and up to 35% in 
equity returns.
This emerged in a panel discussion 
entitled ‘Investing for impact’ during the 
Inclusive Healthcare Innovation Summit 
organised late last month by the University 
of Cape Town’s Graduate School of Business 
(GSB), based at the Mother City’s Foreshore. 
On the panel were several pioneering social 
financiers whose forte is unlocking and 
sourcing funding while minimising risk to 
enable projects that provide financial and 
social returns across a wide spectrum. 
These are specialists in ‘bang-for-buck’ 
social impact through new financing 
instruments that identify the interests 
of each party and align them to achieve 
outcomes that all can commit to. The global 
trailblazer in social impact bonds (SIBs), the 
UK-based Social Finance, has now begun 
a feasibility study on boosting local job 
creation with the GSB’s Bertha Centre for 
Social Innovation and Entrepreneurships 
and Genesis Analytics, funded by the South 
African National Treasury and the Flanders 
Development Agency. The research coalition 
is also looking at education and health as 
potential areas for SIBs. 
With donors cutting back funding since 
the global financial meltdown 6 years ago, 
governments, especially in developing 
countries, are looking for new ways to pay 
for services provided traditionally by non-
governmental organisations. Jane Newman, 
the International Director of Social Finance, 
told the Cape Town seminar that in the 
UK preliminary data suggest that the first 
SIB is contributing to a relative decline 
in re-offending among former prisoners. 
There are 14 SIBs currently commissioned 
in the UK. 
Other areas of exploration for SIBs include 
early identification and self-management of 
diabetes, and social clubs and programmes 
for elderly people to mitigate the burden 
of mental health disorders and accidents/
emergencies. ‘We’re a financial inter mediary 
– our philanthropic-leaning founders’ 
challenge to us was, “can you bring a 
financial lens to tackle social issues, and 
use that to raise broader capital?” We don’t 
divert money already available in any sector, 
but rather look at modest investment costs 
in prevention to generate savings and social 
benefit down the line – for which it’s much 
easier to make a case,’ she stressed.
Comprehensive 
‘blue-collar’ healthcare 
at a fraction of ‘usual’ 
premiums
A local company that has gained traction since 
pioneering affordable low-income-based 
health insurance 6 years ago, is CareCross 
Health, whose off-shoot OCSACare, provides 
‘full-spectrum, unlimited primary care’ for 
blue-collar workers at just R214/month 
(contributed by employers). Their scheme’s 
target members are people earning less than 
R5 000/month. OCSACare has now built up a 
network of 1 400 contracted private GPs, and 
a similar number of dentists, optometrists, 
radiologists and pathologists to provide a 
‘one-man, one-doctor’ service that directly 
reduces health-related or dysfunctional 
(read overburdened) State-clinic related 
absenteeism. According to Statistics South 
Africa, absent workers cost South Africa more 
than R12 billion/year – with a third of public 
sector workers absent for health reasons, 
compared with just over 9% in the private 
sector. 
Drawing from among the more than 
80% of South Africans unable to afford the 
traditional higher-end medical aid premiums 
(often ten times the premium, though two or 
three have followed the CareCross example), 
OCSACare today covers 25  000 members 
– and throws in company education and 
treatment programmes to tackle the two most 
common chronic conditions: hypertension 
and diabetes. The preventive focus includes 
regular reports to management on illness in 
the workplace, which allows companies to 
track and address the most common health 
complaints.
OCSACare’s CEO, Annie Radmanovic, 
cites the Constitution to remind people that 
the onus for providing quality healthcare 
lies not only with government. ‘We’ve 
been able to prove that bringing affordable 
private healthcare to all in South Africa 
is possible,’ she says. CareCross MD, Dr 
Reinder Nauta, says that remunerating GPs 
through risk-share models, e.g capitation, 
ensures an appropriate level of medical care 
at an affordable price point. This form of 
remuneration will also underpin the fee 
models proposed by the National Health 
Insurance. 
CareCross wasn’t the only company looking 
at innovating fee models. Dr Brian Ruff, 
General Manager of Discovery Health, 
noted on several occasions at the summit 
that the current fee-for-service model was 
unsustainable. Nauta quipped that CareCross 
is ‘a not-for-loss company,’ intimating that 
companies who make money in healthcare 
are often frowned upon, but without profit 
there is no sustainability. 
Access to cheaper 
medicines now on the 
horizon
Managing the Cadiz sub-Saharan 
Investment Support Fund (Cadiz ASSIST) 
is former US Agency for International 
Development (USAID) and World Bank 
facilitator, Terry Wyer, now Senior Mana-
ger, Global Partnerships and Impact 
Invest ment at Cadiz Asset Management, 
the Investment Manager of the Southern 
African Regional Programme on Access to 
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Wyer emphasised that it 
was ‘all about de-risking 
investments; the less risk, the 
less return – but a safer, more 
palatable investment’.
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Medicines (SARPAM), Africa Medicines 
Impact Investment Fund (AMIIF). His 
team recently completed a Department 
for International Development-funded 
market assessment on medicine access for 
low-income communities in South Africa, 
Lesotho, Namibia and Botswana. They are 
also in a USAID partnership to finance and 
develop a product using grant funding and 
private sector capital (in this case mainly 
South African pension fund capital) to 
reduce risk on high-impact investments in 
South Africa. 
Their overall goal with AMIIF and their 
international partnerships is to ‘catalyse’ 
private sector investment into the health 
space. ‘Large capital inflows means traction 
and large-scale social impact,’ says Wyer. His 
company provides investment and technical 
assistance; in the process looking at the 
financial health of the prospective partner 
business, their marketing plan, credit-
scoring models and other needs, but, most 
importantly, their social impact. ‘So far we’ve 
not had a single default on these high impact 
projects. We’re actively looking for investors 
and viable businesses,’ he adds. Heavyweight 
partners include the US government, 
Standard Bank, UKaid, Greater Capital, 
African Management Services Company 
(AMSCO), Re-action! Consulting, ETM 
Analytics, Axis (administration), Grant 
Thornton and BLC Legal Counsel.
Carlijn Nouwen is a partner in Dalberg’s 
Johannesburg office (Dalberg being a 
strategic advisory firm working to raise 
living standards in developing countries and 
address global challenges). She has extensive 
expertise in solutions that facilitate bank 
loans to the health sector – something 
virtually unheard of prior to the advent of 
innovative low-risk social impact financing.
One of the most all-embracing 
instruments that Nouwen presented is 
HUGinsure, the first-ever insurance 
entity dedicated to social impact projects. 
HUGinsure is a joint venture between D 
Capital (Dalberg’s impact investment arm) 
and Hollard Insurance, currently piloting 
its first products. Unlike a guarantee, 
HUGinsure provides a way to unpack, 
manage and spread risks. Says Nouwen, 
‘The banks’ major concern is how quickly 
they’ll get their money back. We insure 
very specific risk related to the loans, in 
partnership with major insurance players 
[Hollard Insurance, Lloyd’s of London].’ 
What benefits does HUGinsure bring? 
Among other things, emergency relief 
organisations will no longer need to use such 
huge dormant disaster-relief funds to be 
ready to jump in the next humanitarian crisis. 
A HUGinsure policy will act as a ‘comfort 
wrapper’ for banks to give organisations 
such as Save the Children a credit facility in 
case disaster strikes. Hundreds of millions of 
rands ‘sitting doing nothing’ can be freed up 
to work for social good. 
Dalberg has worked extensively on 
advance purchase agreement mechanisms, 
which enable projects that might otherwise 
never gain traction and secure predictability. 
Where this involves farmers, they can rest 
easy that they’ll sell at a fixed price. 
In Mozambique, D Capital has designed 
a development impact bond to fight malaria 
in partnership with private sector players 
and the government of Mozambique. The 
first issuance of the bond is expected later 
this year.
‘De-risking’ makes it 
possible – and palatable
Asked what the typical range of returns was 
for investors, Wyer said it depended on the 
type of organisation and where on the social 
and financial returns spectrum they were 
aiming. ‘For example, mines get uptime for 
their workers via malaria interventions and 
this is all they need with regards to return 
expectations, but South African investors 
are usually looking for 8 - 10% on debt funds 
as well as social returns and in equity we’re 
looking at 25 - 35% return expectations from 
even some of the so-called development 
institutions. As you go north into Southern 
Africa you can expect larger returns but 
still get tremendous social impact.’ Wyer 
emphasised that it was ‘all about de-risking 
investments; the less risk, the less return – 
but a safer, more palatable investment for 
organisations making these investments.’
Nouwen told seminar delegates that 
impact investors in malaria control received 
a 5 - 10% return on their investment, ‘if 
we’re successful.’ Newman, quizzed on her 
experience of social issue areas that did not 
lend themselves to the mechanism, said it 
was ‘about speed of return on investment 
and depth of the social issue – you’ve seen 
the graph with the peak of expectation, 
trough of desperation and the platform 
of productivity – we’re hoping we’re some 
way towards the last.’ She said confounding 
factors included lack of good or accessible 
data, explaining, ‘with prisoners, police 
computers make access easy, but with drugs 
and alcohol it’s more difficult.’ 
In closing the session, the Bertha Centre’s 
Director, Dr François Bonnici, remarked 
on the growth of the social finance sector, 
saying ‘As this panel has demonstrated, we are 
seeing the emergence of financial instruments 
designed specifically for social enterprises and 
organisations that are creating impact in their 
communities, these instruments are creating 
investment opportunities for impact-oriented 
investors and partnership opportunities for 
governments and corporations. We see this 
space continuing to grow exponentially in size 
and significance.’
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‘Our philanthropic-leaning 
founders’ challenge to 
us was, “can you bring a 
financial lens to tackle social 
issues, and use that to raise 
broader capital?”’ 
